GlassScriptPrepare for your visit
Paul E Later
Neurology (Psychiatry & Neurology) · Fort Wayne, IN · NPI 1689671166
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$132,096.76
in general payments reported to CMS, 2019-2025 · $21K in 2025
The $21K reported for 2025 was more than what 93% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $63,213.01
- Axsome Therapeutics, INC. $15,988.93
- Biohaven Pharmaceuticals, INC. $14,549.53
- Allergan, INC. $13,331.86
- Biogen, INC. $10,760.97
- Pfizer INC. $7,638.40
Drugs and devices associated with these payments
Symbravo Qulipta Ubrelvy Nurtec Odt Vyvgart Zavzpret Ultomiris Gore Cardioform Septal Occluder Vyvgart Hytrulo Botox Zilbrysq Soliris
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Paul Later listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/211819/paul-e-later